Expression of angiotensinogen during hepatic fibro genesis and its effect on hepatic satellite cells

Medical Science Monitor

Volumn 17, Issue 9, 2011, Pages

  Lu, Ping ^a   Liu, Hailin ^a   Yin, Hang ^a   Yang, Liu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Angiotensinogen (AGT); Hepatic satellite cells (HSCS); Liver fibrosis; RNA interfere

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSINOGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; MESSENGER RNA; SHORT HAIRPIN RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROGENESIS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; PLASMID; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL; UPREGULATION;

EID: 80054034723     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881928     Document Type: Article

References (31)

1. Matsubara H, Inada M: Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. Endocr J, 1998; 45: 137-45
2. Friedman SL: Mechanisms of disease: mechanisms of hepatic fbrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol, 2004; 1: 98-105
3. Bataller R, Sancho-Bru P, Gines P et al: Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angioten-sin II. Gastroenterology, 2003; 125: 117-25
4. Bataller R, Gines P, Nicolas JM et al: Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology, 2000; 118: 1149-56
5. Bataller R, Schwabe RF, Choi YH et al: NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fbro-sis. J Clin Invest, 2003; 112: 1383-94
6. Yoshiji H, Kuriyama S, Yoshii J et al: Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fbrosis development. Hepatol Res, 2003; 27: 51-56
7. El-Demerdash E, Salam OM, El-Batran SA et al: Inhibition of the renin-angiotensin system attenuates the development of liver fbrosis and ox-idative stress in rats. Clin Exp Pharmacol Physiol, 2008; 35: 159-67
8. Hirose A, Ono M, Saibara T et al: Angiotensin II type 1 receptor block-er inhibits fbrosis in rat nonalcoholic steatohepatitis. Hepatology, 2007; 45: 1375-81
9. Kim MY, Baik SK, Park DH et al: Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fbrosis in a bile duct-ligated rat model. J Gastroenterol, 2008; 43: 889-96
10. Terui Y, Saito T, Watanabe H et al: Effect of angiotensin receptor antagonist on liver fbrosis in early stages of chronic hepatitis C. Hepatology, 2002; 36: 1022
11. Yokohama S, Yoneda M, Haneda M et al: Therapeutic effcacy of an an-giotensin II receptor antagonist in patients with nonalcoholic steato-hepatitis. Hepatology, 2004; 40: 1222-25
12. Yokohama S, Tokusashi Y, Nakamura K et al: Inhibitory effect of angio-tensin II receptor antagonist on hepatic stellate cell activation in nonalcoholic steatohepatitis. World J Gastroenterol, 2006; 12: 322-26
13. Paizis G, Cooper ME, Schembri JM et al: Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology, 2002; 123: 1667-76
14. Safadi R, Friedman SL: Hepatic fbrosis - role of hepatic stellate cell activation. Med Gen Med, 2002; 4: 27
15. Bataller R, Brenner DA: Liver fbrosis. J Clin InVest, 2005; 115: 209-18
16. Aleynik SI, Leo MA, Ma X et al: Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid per oxidation while it attenuates liver fbrosis. J Hepatol, 1997; 27: 554-56
17. Friedman SL: Mechanisms of hepatic fbrogenesis. Gastroenterology, 2008; 134, 1655-69
18. Moreira, PK: Hepatic stellate cells and liver fbrosis. Arch Pathol Lab Med, 2007; 131: 1728-34
19. Geerts A: History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis, 2001; 21: 311-35
20. Kurikawa N, Suga M, Kuroda S et al: An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver f-brosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol, 2003; 139: 1085-94
21. Yichun W, Qiang W, Yan Y et al: The activation and proliferation of HSCs and the altered expression of transforming growth factor beta-1 and its type I receptor in the middle and late stage of rat hepatic fbrosis and the effect of liver-aid tables on them. Chin J Histochem Cytochem, 2007; 16: 80-86
22. Jonsson JR, Clouston AD, Ando Y et al: Angiotensin-Converting Enzyme Inhibition Attenuates the Progression of Rat Hepatic Fibrosis. Gastroenterology, 2001; 121: 148-55
23. Ikura Y, Ohsawa M, Shirai N et al: Expression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fbrosis and portal hypertension. Hepatol Res, 2005; 32: 107-16
24. Komeda K, Jin D, Takai S et al: Signifcance of chymase-dependent angiotensin II formation in the progression of human liver fbrosis. Hepatol Res, 2008; 38: 501-10
25. Colmenero J, Bataller R, Sancho-Bru P et al: Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology, 2007; 132: 687-97
26. Yarmi K, Nihu Y, Marakami K et al: A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J Biol Chem, 1998; 271: 15981-5
27. Powell EE, Edwards-Smith CJ, Hay JL et al: Host genetic factors infu-ence disease progression in chronic hepatitis C. Hepatology, 2000; 31: 828-33
28. Dixon JB, Bhathal PS, Jonsson JR et al: Pro-fbrotic polymorphisms predictive of advanced liver fbrosis in the severely obese. J Hepatol, 2003; 39: 967-71
29. Dai WJ, Jiang HC: Advances in gene therapy of liver cirrhosis: a review. World J Gastroenterol, 2001; 7: 1-8
30. Vogel S, Piantedosi R, Frank J et al: An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res, 2000; 41: 882-93
31. Gaedeke J, Peters H, Noble NA et al: TGF-beta and renal fbrosis. Contrib Nephrol, 2001; 135: 153-60